Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully raised a sum of $110 million Series E financing.
Led by a...
StemCyte has officially announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long...
For drug developers working on oral solid dosage drug projects, solubility, and therefore bioavailability, is a significant challenge. At present, poor water solubility impacts...